The Defense Health Agency awarded Levisonics Inc., a woman-owned small business and manufacturer of medical devices, a $4,313,357 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on March 15, 2024. The funding supports the development of a point-of-care diagnostic and management system for trauma-related coagulation disorders using Levisonics' proprietary acoustic tweezing spectroscopy (ATS) platform. The ATS technology aims to provide comprehensive coagulation profiles from a single drop of whole blood, enabling more convenient and less invasive coagulation testing, particularly for vulnerable patient populations like neonates and children. This grant builds on Levisonics' previous federal awards from agencies like the National Heart Lung and Blood Institute and the National Science Foundation to advance its ATS platform for various coagulation monitoring and analysis applications.
Generated 12/10/24, 7:52 AM